Description
Bendamustine: a therapy from the past, for the present and future, in daily clinical practice
- You cannot add another "Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer" to your cart. View cart
Article: Bendamustine: a therapy from the past, for the present and future, in daily clinical practice
€3.03
Reviews
There are no reviews yet.